Impact of alpha-fetoprotein on hepatocellular carcinoma development during entecavir treatment of chronic hepatitis B virus infection

被引：0

作者：

Ryoko Yamada

Naoki Hiramatsu

Tsugiko Oze

Naoki Morishita

Naoki Harada

Takayuki Yakushijin

Sadaharu Iio

Yoshinori Doi

Akira Yamada

Akira Kaneko

Hideki Hagiwara

Eiji Mita

Masahide Oshita

Toshifumi Itoh

Hiroyuki Fukui

Taizo Hijioka

Kazuhiro Katayama

Shinji Tamura

Harumasa Yoshihara

Yasuharu Imai

Michio Kato

Takuya Miyagi

Yuichi Yoshida

Tomohide Tatsumi

Akinori Kasahara

Toshimitsu Hamasaki

Norio Hayashi

Tetsuo Takehara

机构：

[1] Osaka University Graduate School of Medicine,Department of Gastroenterology and Hepatology

[2] Higashiosaka City Central Hospital,Department of General Medicine

[3] Otemae Hospital,Department of Biomedical Statistics

[4] Sumitomo Hospital,undefined

[5] NTT West Osaka Hospital,undefined

[6] Kansai Rosai Hospital,undefined

[7] National Hospital Organization Osaka National Hospital,undefined

[8] Osaka Police Hospital,undefined

[9] Japan Community Health Care Organization Osaka Hospital,undefined

[10] Yao Municipal Hospital,undefined

[11] National Hospital Organization Osaka Minami Medical Center,undefined

[12] Osaka Medical Center for Cancer and Cardiovascular Diseases,undefined

[13] Minoh City Hospital,undefined

[14] Osaka Rosai Hospital,undefined

[15] Ikeda Municipal Hospital,undefined

[16] National Hospital Organization Minami Wakayama Medical Center,undefined

[17] Osaka University Hospital,undefined

[18] Osaka University Graduate School of Medicine,undefined

来源：

Journal of Gastroenterology | 2015年 / 50卷

关键词：

Hepatitis B virus; Entecavir; Risk factors for hepatocellular carcinoma incidence; Alpha-fetoprotein;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：785 / 794

页数：9

共 50 条

[1] Impact of alpha-fetoprotein on hepatocellular carcinoma development during entecavir treatment of chronic hepatitis B virus infection
Yamada, Ryoko
Hiramatsu, Naoki
Oze, Tsugiko
Morishita, Naoki
Harada, Naoki
Yakushijin, Takayuki
Iio, Sadaharu
Doi, Yoshinori
Yamada, Akira
Kaneko, Akira
Hagiwara, Hideki
Mita, Eiji
Oshita, Masahide
Itoh, Toshifumi
Fukui, Hiroyuki
Hijioka, Taizo
Katayama, Kazuhiro
Tamura, Shinji
Yoshihara, Harumasa
Imai, Yasuharu
Kato, Michio
Miyagi, Takuya
Yoshida, Yuichi
Tatsumi, Tomohide
Kasahara, Akinori
Hamasaki, Toshimitsu
Hayashi, Norio
Takehara, Tetsuo
JOURNAL OF GASTROENTEROLOGY, 2015, 50 (07) : 785 - 794
[2] Revisit of Alpha-fetoprotein as a Tumor Marker for Hepatocellular Carcinoma in Chronic Hepatitis B Patients Receiving Entecavir
Chan, Henry Lik-Yuen
Wong, Grace L. H.
Lo, Angeline O. S.
Wong, Vincent W.
HEPATOLOGY, 2013, 58 : 1256A - 1256A
[3] On-Treatment Alpha-Fetoprotein Is a Specific Tumor Marker for Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Receiving Entecavir
Wong, Grace L. H.
Chan, Henry L. Y.
Tse, Yee-Kit
Chan, Hoi-Yun
Tse, Chi-Hang
Lo, Angeline O. S.
Wong, Vincent W. S.
HEPATOLOGY, 2014, 59 (03) : 986 - 995
[4] Impact of pre-treatment platelet count on hepatocellular carcinoma development during entecavir treatment of chronic hepatitis B virus infection
Kawano, Akira
Shigematsu, Hirohisa
Miki, Koichiro
Tanimoto, Hironori
Ichiki, Yasunori
Morita, Chie
Yanagita, Kimihiko
Takahashi, Kazuhiro
Dohmen, Kazufumi
Seike, Masataka
Nomura, Hideyuki
Ishibashi, Hiromi
Shimoda, Shinji
HEPATOLOGY, 2015, 62 : 1199A - 1199A
[5] On-treatment alpha-fetoprotein levels have a strong association with hepatocellular carcinoma development among chronic hepatitis B patients receiving entecavir
Yamada, Ryoko
Hiramatsu, Naoki
Tahata, Yuki
Morishita, Naoki
Harada, Naoki
Oze, Tsugiko
Yakushijin, Takayuki
Iio, Sadaharu
Doi, Yoshinori
Mita, Eiji
Oshita, Masahide
Ito, Toshifumi
Hijioka, Taizo
Katayama, Kazuhiro
Tamura, Shinji
Yoshihara, Harumasa
Imai, Yasuharu
Miyagi, Takuya
Yoshida, Yuichi
Tatsumi, Tomohide
Hayashi, Norio
Takehara, Tetsuo
HEPATOLOGY, 2014, 60 : 1091A - 1092A
[6] HEPATITIS-B VIRUS, ALPHA-FETOPROTEIN SYNTHESIS, AND HEPATOCELLULAR-CARCINOMA IN ZAIRE
KASHALA, LO
CONNE, B
KAPANCI, Y
FREI, PC
LAMBERT, PH
KALENGAYI, MR
ESSEX, M
LIVER, 1992, 12 (05): : 330 - 340
[7] Alpha-Fetoprotein Measurement Improves Hepatocellular Carcinoma Surveillance in Chronic Hepatitis B Patients with Cirrhosis
Kim, Mina
Hwang, Seong-Gyu
Kim, Beom Kyung
Kim, Seung Up
Park, Jun Yong
Ahn, Sang Hoon
Han, Kwang-Hyub
Kim, Do Young
HEPATOLOGY, 2018, 68 : 1237A - 1237A
[8] ALPHA-FETOPROTEIN MONITORING IN CHINESE PATIENTS WITH CHRONIC HEPATITIS-B VIRUS-INFECTION - ROLE IN THE EARLY DETECTION OF HEPATOCELLULAR-CARCINOMA
LOK, ASF
LAI, CL
HEPATOLOGY, 1989, 9 (01) : 110 - 115
[9] Entecavir for the treatment of chronic hepatitis B virus infection
Matthews, SJ
CLINICAL THERAPEUTICS, 2006, 28 (02) : 184 - 203
[10] Serum Alpha-Fetoprotein Levels During and After Interferon Therapy and the Development of Hepatocellular Carcinoma in Patients with Chronic Hepatitis C
Yasushi Tamura
Satoshi Yamagiwa
Yohei Aoki
So Kurita
Takeshi Suda
Shogo Ohkoshi
Minoru Nomoto
Yutaka Aoyagi
Digestive Diseases and Sciences, 2009, 54 : 2530 - 2537

← 1 2 3 4 5 →